Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.
ImpactNotable
Published3 d ago (Mon, 09 Nov 2026 14:30:01 GMT)
MoreLess
Impact score30/100
RatingRule-based estimate: no strong signals; trust 7/10.
RegionsGlobal
Retrievedvia rss
ClassifiedTue, 10 Nov 2026 00:00:23 GMT by heuristic